We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-8.09%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$176M
AUM Growth
-$66.3M
Cap. Flow
-$43.6M
Cap. Flow %
-24.78%
Top 10 Hldgs %
39.96%
Holding
51
New
2
Increased
12
Reduced
17
Closed
13

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.98M
2
A icon
Agilent Technologies
A
+$3.69M
3
LLY icon
Eli Lilly
LLY
+$3.45M
4
SYK icon
Stryker
SYK
+$2.47M
5
NVO
Novo Nordisk
NVO
+$1.66M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$7.51M
2
CVS icon
CVS Health
CVS
+$6.07M
3
LH icon
Labcorp
LH
+$5.27M
4
GMED icon
Globus Medical
GMED
+$4.8M
5
CYH icon
Community Health Systems
CYH
+$3.56M

Sector Composition

Rank Sector Weight
1 Healthcare 96.12%
2 Energy 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
1
UnitedHealth
UNH
$367B
$7.96M 4.52%
15,500
-1,500
-9% -$753K
MCK icon
2
McKesson
MCK
$102B
$7.34M 4.17%
22,500
– –
HUM icon
3
Humana
HUM
$44.1B
$7.25M 4.12%
15,500
-2,500
-14% -$1.11M
ELV icon
4
Elevance Health
ELV
$84.9B
$7.24M 4.11%
15,000
– –
LLY icon
5
Eli Lilly
LLY
$1.06T
$6.97M 3.96%
21,502
+11,502
+115% +$3.45M
BSX icon
6
Boston Scientific
BSX
$71.4B
$6.89M 3.92%
185,000
-15,000
-8% -$611K
TMO icon
7
Thermo Fisher Scientific
TMO
$214B
$6.79M 3.86%
12,500
– –
NVO
8
Novo Nordisk
NVO
$203B
$6.69M 3.8%
120,000
+30,000
+33% +$1.66M
DHR icon
9
Danaher
DHR
$141B
$6.59M 3.75%
29,328
-1,692
-5% -$390K
CI icon
10
Cigna
CI
$72.7B
$6.59M 3.74%
25,000
+5,000
+25% +$1.29M
CNC icon
11
Centene
CNC
$31.7B
$6.35M 3.61%
75,000
+5,000
+7% +$415K
SYK icon
12
Stryker
SYK
$129B
$6.07M 3.45%
30,500
+10,500
+53% +$2.47M
COR icon
13
Cencora
COR
$63.2B
$5.66M 3.22%
40,000
– –
ZBH icon
14
Zimmer Biomet
ZBH
$18.8B
$5.25M 2.98%
50,000
+10,000
+25% +$1.19M
UHS icon
15
Universal Health Services
UHS
$10.3B
$4.78M 2.72%
47,500
– –
ACHC icon
16
Acadia Healthcare
ACHC
$2.86B
$4.73M 2.69%
70,000
+20,000
+40% +$1.4M
HCA icon
17
HCA Healthcare
HCA
$88.5B
$4.62M 2.63%
27,500
+5,000
+22% +$1.07M
JNJ icon
18
Johnson & Johnson
JNJ
$619B
$4.44M 2.52%
25,000
-10,000
-29% -$1.78M
ABT icon
19
Abbott
ABT
$187B
$4.35M 2.47%
40,000
-5,000
-11% -$568K
BAX icon
20
Baxter International
BAX
$14B
$4.17M 2.37%
65,000
+5,000
+8% +$363K
ISRG icon
21
Intuitive Surgical
ISRG
$132B
$4.01M 2.28%
20,000
-2,500
-11% -$587K
BMRN icon
22
BioMarin Pharmaceuticals
BMRN
$11.9B
$3.94M 2.24%
47,500
+7,500
+19% +$597K
IQV icon
23
IQVIA
IQV
$38.3B
$3.8M 2.16%
17,500
-2,500
-13% -$543K
SNY icon
24
Sanofi
SNY
$104B
$3.75M 2.13%
+75,000
New +$3.98M
XBI icon
25
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$3.71M 2.11%
50,000
-100,000
-67% -$7.51M
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return
MFG
Macco Financial Group Green Bay, Wisconsin $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM

Sivik Global Healthcare's Q2 2022 Portfolio in Review

As of Q2 2022, Sivik Global Healthcare held 51 positions worth $176M, down 27% from $242M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sivik Global Healthcare withdrew a net $43.6M in Q2 2022, closing 13 positions and reducing 17 holdings. Its most notable exit was CVS Health, an estimated $6.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 93% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Sanofi worth $3.75M.

  • Sivik Global Healthcare's largest Q2 2022 buy was Sanofi: 75,000 shares worth $3.75M.
  • Sivik Global Healthcare added most to Eli Lilly in Q2 2022, an estimated $3.45M increase.
  • Sivik Global Healthcare's biggest Q2 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $7.51M.
  • Sivik Global Healthcare fully exited CVS Health in Q2 2022, selling an estimated $6.07M.
  • Sivik Global Healthcare's ten largest holdings make up 40% of its $176M portfolio in Q2 2022.
  • Sivik Global Healthcare opened 2 new positions and closed 13 in Q2 2022.
  • Sivik Global Healthcare's portfolio value fell 27% quarter-over-quarter to $176M.

Based on Sivik Global Healthcare's 13F filing for Q2 2022, filed 10 Aug 2022.